Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,095 | 1,416 | 1,693 | 1,893 | 1,660 |
| Income taxes - deferred | -1,457 | 1,544 | -493 | 1,317 | 1,398 |
| Accounts receivable | -1,787 | -2,225 | 1,732 | 2,730 | 549 |
| Other Working Capital | 1,625 | -5,065 | 3,738 | 1,995 | 1,661 |
| Other Operating Activity | 2,802 | 2,859 | 760 | -1,335 | 1,666 |
| Operating Cash Flow | $3,278 | $-1,470 | $7,430 | $6,600 | $6,934 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,108 | -5,008 | -5,404 | -3,269 | -1,191 |
| Investing Cash Flow | $-3,108 | $-5,008 | $-5,404 | $-3,269 | $-1,191 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -581 | -397 | 12,876 | -2,414 | -5,702 |
| Financing Cash Flow | $-581 | $-397 | $12,876 | $-2,414 | $-5,702 |
| Exchange Rate Effect | N/A | N/A | 61 | -102 | -41 |
| Beginning Cash Position | 8,306 | 15,181 | 816 | 0 | 0 |
| End Cash Position | 8,065 | 8,306 | 15,779 | 816 | 0 |
| Net Cash Flow | $-412 | $-6,876 | $14,902 | $918 | $41 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,278 | -1,470 | 7,430 | 6,600 | 6,934 |
| Capital Expenditure | -3,180 | -5,019 | -5,447 | -3,274 | -1,257 |
| Free Cash Flow | 98 | -6,489 | 1,984 | 3,326 | 5,677 |